missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Adenosine-5'-Diphosphate Disodium Salt, MP Biomedicals™
Involved in energy storage and nucleic acid metabolism. Adenosine-5'-Diphosphate Disodium Salt, MP Biomedicals is an adenine nucleotide that converts into ATP by ATP synthases. ADP affects platelet activation through its interaction with ADP receptors.
$174.14 - $174.14
Chemical Identifiers
| CAS | 16178-48-6 |
|---|---|
| Molecular Formula | C10H13N5Na2O10P2 |
| Molecular Weight (g/mol) | 471.17 |
| MDL Number | MFCD00150927 |
| InChI Key | ORKSTPSQHZNDSC-WCYUCLFNNA-L |
| Synonym | adenosine 5'-diphosphate disodium salt, adenosine-5'-diphosphate disodium salt, sodium 2r,3s,4r,5r-5-6-amino-9h-purin-9-yl-3,4-dihydroxytetrahydrofuran-2-yl methyl hydrogendiphosphate, adenosine 5'-diphosphate disodium salt hydrate, adenosine, 5'-diphosphoric acid, disodium salt, adenosine 5'-trihydrogen diphosphate , disodium salt, trinosin s hydrate, disodium hydrogen 2r,3s,4r,5r-5-6-aminopurin-9-yl-3,4-dihydroxyoxolan-2-yl methyl phosphonato oxyphosphonate, adenosine 5'-trihydrogen diphosphate , sodium salt 1:2, disodium adp hydrate |
| PubChem CID | 85315 |
| IUPAC Name | disodium;[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-oxidophosphoryl] hydrogen phosphate |
| SMILES | [Na+].[Na+].NC1=C2N=CN([C@@H]3O[C@H](COP([O-])(=O)OP(O)([O-])=O)[C@@H](O)[C@H]3O)C2=NC=N1 |
| Catalog Number | Mfr. No. | Quantity | Price | Quantity | |||||
|---|---|---|---|---|---|---|---|---|---|
| Catalog Number | Mfr. No. | Quantity | Price | Quantity | |||||
|
MP21000565
|
MP Biomedicals Inc
021000565 |
500 mg |
Each for $174.14
|
|
|||||
Description
ADP affects platelet activation through its interaction with ADP receptors P2Y1, P2Y12 and P2X1. Upon its conversion to adenosine by ecto-ADPases, platelet activation is inhibited via adenosine receptors.
Chemical Identifiers
| 16178-48-6 | |
| 471.17 | |
| ORKSTPSQHZNDSC-WCYUCLFNNA-L | |
| 85315 | |
| [Na+].[Na+].NC1=C2N=CN([C@@H]3O[C@H](COP([O-])(=O)OP(O)([O-])=O)[C@@H](O)[C@H]3O)C2=NC=N1 |
| C10H13N5Na2O10P2 | |
| MFCD00150927 | |
| adenosine 5'-diphosphate disodium salt, adenosine-5'-diphosphate disodium salt, sodium 2r,3s,4r,5r-5-6-amino-9h-purin-9-yl-3,4-dihydroxytetrahydrofuran-2-yl methyl hydrogendiphosphate, adenosine 5'-diphosphate disodium salt hydrate, adenosine, 5'-diphosphoric acid, disodium salt, adenosine 5'-trihydrogen diphosphate , disodium salt, trinosin s hydrate, disodium hydrogen 2r,3s,4r,5r-5-6-aminopurin-9-yl-3,4-dihydroxyoxolan-2-yl methyl phosphonato oxyphosphonate, adenosine 5'-trihydrogen diphosphate , sodium salt 1:2, disodium adp hydrate | |
| disodium;[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-oxidophosphoryl] hydrogen phosphate |
Specifications
| 16178-48-6 | |
| MFCD00150927 | |
| adenosine 5'-diphosphate disodium salt, adenosine-5'-diphosphate disodium salt, sodium 2r,3s,4r,5r-5-6-amino-9h-purin-9-yl-3,4-dihydroxytetrahydrofuran-2-yl methyl hydrogendiphosphate, adenosine 5'-diphosphate disodium salt hydrate, adenosine, 5'-diphosphoric acid, disodium salt, adenosine 5'-trihydrogen diphosphate , disodium salt, trinosin s hydrate, disodium hydrogen 2r,3s,4r,5r-5-6-aminopurin-9-yl-3,4-dihydroxyoxolan-2-yl methyl phosphonato oxyphosphonate, adenosine 5'-trihydrogen diphosphate , sodium salt 1:2, disodium adp hydrate | |
| [α]20/D -29.6±1° c = 0.5% in 0.5M Na2HPO4 (Lit.) | |
| disodium;[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-oxidophosphoryl] hydrogen phosphate | |
| 85315 | |
| ≥95% |
| C10H13N5Na2O10P2 | |
| 500 mg | |
| ORKSTPSQHZNDSC-WCYUCLFNNA-L | |
| [Na+].[Na+].NC1=C2N=CN([C@@H]3O[C@H](COP([O-])(=O)OP(O)([O-])=O)[C@@H](O)[C@H]3O)C2=NC=N1 | |
| 471.17 | |
| 471.2 | |
| Powder |
Safety and Handling
Recommended Storage : Store at −20°C.